Sequence Bio
Discovering the true signals of disease to power life-changing drugs.
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
90% of drug candidates fail, delaying help for those in need. We’re on a mission to change that. Better drug target discovery powered by the Newfoundland founder effect. Sequence Bio is a Y Combinator company (Summer 2019). YC-listed status: Active.
- Website
- sequencebio.com
- Location
- St. John's, NL, Canada
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- Sequence Bio — Genetics research platform discovering causal drug targets using Newfoundland's founder-effect population cohort. · Service
Links
- Y Combinator profileycombinator